Skip to main content
OpenTrials

Clinical trial condition

Pituitary Diseases

Explore clinical trials studying Pituitary Diseases. Study availability and eligibility vary by location and protocol.

50 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Pituitary Diseases trial results

Completed

A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

NCT02781727

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +16 more
Locations
  • Ascendis Pharma Investigational Site Birmingham, Alabama, United States
  • Ascendis Pharma Investigational Site Little Rock, Arkansas, United States
  • Ascendis Pharma Investigational Site Los Angeles, California, United States
  • Ascendis Pharma Investigational Site Orange, California, United States
View all 53 locations
View Trial Details
Completed

A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency

NCT03305016

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +15 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Neufeld Medical Group Inc. Los Angeles, California, United States
  • Center of Excellence in Diabetes and Endocrinology Sacramento, California, United States
  • Rocky Mountain Pediatric Endocrinology Centennial, Colorado, United States
View all 24 locations
View Trial Details
Completed

A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial

NCT03344458

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +15 more
Locations
  • Ascendis Pharma Investigational Site Birmingham, Alabama, United States
  • Ascendis Pharma Investigational Site Los Angeles, California, United States
  • Ascendis Pharma Investigational Site Orange, California, United States
  • Ascendis Pharma Investigational Site Sacramento, California, United States
View all 42 locations
View Trial Details
Completed

Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors

NCT04042753

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +16 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
View Trial Details
Completed

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

NCT05199584

Conditions
Adenoma, Adenoma, Islet Cell, Brain Diseases, +52 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Santa Rosa, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Zion, Illinois, United States
View all 16 locations
View Trial Details

Related conditions